Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Risk Assessment Tool for Incontinence-associated Dermatitis (IAD): a Cohort Study on the Predictive Performance of Risk Factors for IAD

NCT06978751 is registered in ClinicalTrials.gov with Örebro University, Sweden as lead sponsor.

NCT NCT06978751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06978751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Risk Assessment Tool for Incontinence-associated Dermatitis (IAD): a Cohort Study on the Predictive Performance of Risk Factors for IAD
Lead sponsor
Örebro University, Sweden
Phase
Observational
Overall status
Completed
Start date
May 13, 2025
Completion date
May 18, 2026
Enrollment
271 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

incontinence associated dermatitis